Physicians' attitudes and acceptance regarding COVID-19 vaccines: a cross-sectional study in mid Delta region of Egypt

Environ Sci Pollut Res Int. 2022 Mar;29(11):15838-15848. doi: 10.1007/s11356-021-16574-8. Epub 2021 Oct 11.

Abstract

Safe and effective vaccines became an important preventive tool against novel corona virus disease infection. Physicians were prioritized for early vaccination since they are at higher risk for contagion of the infection and they might affect the general populations' uptake of the vaccine. This study aimed to examine the acceptability of COVID-19 vaccines and the underpinnings of reluctance to uptake the vaccine among working physicians in Egypt. A cross-sectional study was conducted for 3 months, recruiting 1268 physicians using a snowballing random sampling technique. A self-administered electronic questionnaire was deployed to collect related data. Of participants, 24% expressed their acceptance towards COVID-19 vaccines, 39% would wait for further review, while 36.7% did not agree to get vaccinated. Findings revealed that 22% of them were vaccinated and the significant determinants of unacceptability included age, gender, higher educational attainments, prior infection, lack of direct patients' contact, and working in rural health facilities (p < 0.05). The most common reasons beyond their reluctance were fear of the vaccines' adverse effects and the short duration of its clinical trials (60% and 49.5%). Physicians had a low intention to receive COVID-19 vaccines particularly between females, senior staff, and those who had a low self-perceived risk for the infection. Integrated approaches should be designed to address concerns and factors associated with vaccine unacceptability to reduce vaccination reluctance between physicians, hence the general population.

Keywords: Acceptance; COVID-19; Egypt; Healthcare workers (HCWs); Infection; Physicians; Vaccines.

MeSH terms

  • Attitude
  • COVID-19 Vaccines
  • COVID-19*
  • Cross-Sectional Studies
  • Egypt
  • Female
  • Humans
  • Physicians*
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines